These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 8794987

  • 61. Effects of free and macromolecular-bound TXA2 receptor antagonist BM 13.505 on U46619-induced platelet aggregation.
    Klimm JL, Kloczewiak MA, Lindon J.
    Prostaglandins; 1993 Jul; 46(1):27-36. PubMed ID: 8378540
    [Abstract] [Full Text] [Related]

  • 62. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH, Woodward DF, Burk RM, Gac TS, Gibson LL, Protzman CE, Abbass F, Marshall K, Senior J.
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
    [Abstract] [Full Text] [Related]

  • 63. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA, Doran JB, Smith B, FitzGerald GA.
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [Abstract] [Full Text] [Related]

  • 64. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 65. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
    Molimard M, Martin CA, Naline E, Hirsch A, Advenier C.
    Eur J Pharmacol; 1995 May 04; 278(1):49-54. PubMed ID: 7545124
    [Abstract] [Full Text] [Related]

  • 66. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
    Johnson GJ, Leis LA, Dunlop PC.
    J Clin Invest; 1993 Nov 04; 92(5):2469-79. PubMed ID: 8227362
    [Abstract] [Full Text] [Related]

  • 67. Inhibitory effect of vapiprost on contractile responses of isolated dog renal arteries to thromboxane A2 analogue, U46619.
    Sakanashi M, Matsuzaki T, Noguchi K, Nakasone J, Itomine T, Uza M, Toyama F, Higuchi M.
    Gen Pharmacol; 1994 Jul 04; 25(4):617-22. PubMed ID: 7958719
    [Abstract] [Full Text] [Related]

  • 68. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P, Dho L, Ukmar G, Vaga L, Rimoldi O, Patrono C.
    J Pharmacol Exp Ther; 1994 Apr 04; 269(1):238-45. PubMed ID: 8169831
    [Abstract] [Full Text] [Related]

  • 69. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
    Wilkes BM, Mento PF, Hollander AM.
    Placenta; 1994 Dec 04; 15(8):845-55. PubMed ID: 7886025
    [Abstract] [Full Text] [Related]

  • 70. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F, Valentin JP, Maffre M, Grelac F, Bessac AM, Maclouf J, Delhon A, Lévy-Toledano S, Patoiseau JF, Colpaert FC.
    Br J Pharmacol; 1995 May 04; 115(1):210-6. PubMed ID: 7647979
    [Abstract] [Full Text] [Related]

  • 71. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice.
    Darius H, Lefer AM.
    Proc Soc Exp Biol Med; 1985 Nov 04; 180(2):364-8. PubMed ID: 2996012
    [Abstract] [Full Text] [Related]

  • 72. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP, Villalobos MA, Escalante R, Guerrero A, Arrebola MM, Sánchez de La Cuesta F.
    Br J Pharmacol; 2002 Dec 04; 137(7):1082-8. PubMed ID: 12429581
    [Abstract] [Full Text] [Related]

  • 73. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
    Martin SE, Kuvin JT, Offenbacher S, Odle BM, Patterson RE.
    Am J Physiol; 1992 Oct 04; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
    [Abstract] [Full Text] [Related]

  • 74. Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist.
    Friedhoff LT, Manning J, Funke PT, Ivashkiv E, Tu J, Cooper W, Willard DA.
    Clin Pharmacol Ther; 1986 Dec 04; 40(6):634-42. PubMed ID: 3780125
    [Abstract] [Full Text] [Related]

  • 75. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
    Sanderson HM, Heptinstall S, Vickers J, Lösche W.
    Blood Coagul Fibrinolysis; 1996 Mar 04; 7(2):245-8. PubMed ID: 8735830
    [Abstract] [Full Text] [Related]

  • 76. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S, Ogawa N, Suzuki T, Kato K, Ohashi T, Yasuda S, Kato H, Ito Y.
    Chem Pharm Bull (Tokyo); 1996 Apr 04; 44(4):765-77. PubMed ID: 8681409
    [Abstract] [Full Text] [Related]

  • 77. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT.
    Circulation; 1984 Jun 04; 69(6):1161-70. PubMed ID: 6546902
    [Abstract] [Full Text] [Related]

  • 78. Abnormal platelet response to thromboxane A2.
    Wu KK, Le Breton GC, Tai HH, Chen YC.
    J Clin Invest; 1981 Jun 04; 67(6):1801-4. PubMed ID: 6263954
    [Abstract] [Full Text] [Related]

  • 79. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
    Krauss AH, Woodward DF, Chen J, Gibson LL, Lai RK, Protzman CE, Shan T, Williams LS, Gac TS, Burk RM.
    J Ocul Pharmacol Ther; 1995 Jun 04; 11(3):203-12. PubMed ID: 8590251
    [Abstract] [Full Text] [Related]

  • 80. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 3. Pyridinylalkyl-substituted 8-[(arylsulfonyl)amino]octanoic acids.
    Main AJ, Bhagwat SS, Boswell C, Goldstein R, Gude C, Cohen DS, Furness P, Lee W, Louzan M.
    J Med Chem; 1992 Nov 13; 35(23):4366-72. PubMed ID: 1447737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.